ScottJ.CameronMDPhD

Vascular Medicine

Cardiologist, Vascular Medicine Physician, Platelet Biologist.

Dr. Cameron is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Dr. Scott Cameron is a cardiologist in Cleveland, OH and affiliated with Cleveland Clinic where he is the Section Head of Vascular Medicine with dual appointments in cardiovascular medicine and in hematology. He received his medical degree from State University of New York Upstate Medical University and his residency training at New York Presbyterian Hospital, and has been in independent practice 10 years. He specializes in vascular medicine and in general cardiology, peripheral vascular disease, platelet dysfunction, hematology, pulmonary embolism, coronary thrombosis, and vascular ultrasonography.

Thrombotic Emergencies, Pulmonary embolism, Platelet Activation, Coronary thrombosis, Coronary Care Units, Endothelial Cells, General cardiology, Peripheral vascular disease, Vascular ultrasonography, Atrial fibrillation, Heart failure, Systolic heart failure, Lymphedemea, Thoracic outlet syndrome, Chronic venous insufficiency , Loeys-Dietz syndrome, Dyslipidemia, Palpitations, Fibromuscular dyplasia, Cerebral aneurysm, Celiac artery compression syndrome, Ehlers-Danlos syndrome type VI, Abdominal aortic aneurysm, Coronary arterty, Heparin-induced thrombocytopenia

University of RochesterFellowship, Cardiovascular Disease, 2011 - 2016
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2009 - 2011
SUNY Upstate Medical UniversityClass of 2009
Johns Hopkins UniversityFellowship, Vascular Medicine

NY State Medical License 2011 - 2026
OH State Medical License 2019 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Cardiovascular Disease
Alliance for Physician Certification and AdvancementRegistered physician in vascular interpretation
American Board of Vascular MedicineVascular Medicine
National Board of Medical Examiners

The Gill Heart and Vascular Institute Award for Early Career Achievements in Cardiovascular Research The Gill Foundation, 2022
ACC Young Investigator Award American College of Cardiology, 2019
Oustanding Young Alumnus SUNY Upstate Medical University, 2019
K Grant Awardee Central Society for Clinical and Translational Research, 2018
Medicine resident research mentoring award University of Rochester, 2018
Jay D. Coffman YI Award in Basic Science (2nd Place) Society of Vascular Medicine, 2016
NIH NHLB T32 Training Grant (Pulmonary Medicine) National Institute of Health
Platelet Colloquium Career Investigator Award University of Kentucky, 2015
Best of the Best, AHA Subspecialty Conference Presentations American Heart Association, 2015
American College of Cardiology NY State Research Award American College of Cardiology, 2014-2015
Join now to see all

PubMed

1 citations
Soluble glycoprotein VI predicts abdominal aortic aneurysm growth rate and is a novel therapeutic target.
Tyler W Benson, Mindy M Pike, Anthony Spuzzillo, Sarah M Hicks, Sidra Ali
Blood. 2024-10-17
Stop the clot: When is laboratory evaluation for thrombophilia warranted?
Jaideep Singh Bhalla, G Jay Bishop, Scott J Cameron
Cleveland Clinic Journal of Medicine. 2024-09-03
Sex-dependent niche responses modulate steady-state and regenerative hematopoiesis.
Rahul Chaudhary, Julianne N P Smith, Riya Tiwari, Bailey R Klein, Brittany A Cordova
Experimental Hematology. 2024-09-01

Lectures

A Switch in Platelet Surface Receptor Signaling at the Time of Myocardial Infraction Occurs in Humans and Mice: Implications For Anti-Platelet Therapy in Men and Women
2019 ACC Scientific Session & Expo, New Orleans - 3/16/2019

6 Lifestyle Tips for Life After Blood ClotsJuly 15th, 2022
Cohort Study Shows Association Between PERT Implementation and Mortality in Patients with High-Risk PEJanuary 3rd, 2022
New section headAugust 1st, 2021
Join now to see all

Platelets as biosensors and mediators of aortic aneurysm growth.National heart lungs and blood Institute2021–2026
Platelets as Biosensors and Mediators of Metabolism in LipedemaLipedema Foundation2021–2023
Platelet ERK5 regulates myocardial infarct expansion (Principle Investigator)National Institute of Health2016–2021
Drug discovery grant: Novel platelet modulating agents.Clinical and Translational Science Institute2018–2019
ERK5 and Platelet DysregulationNational Institute of Health - Division of Loan Repayments (Clinical Research)2013–2019
Platelet Dysregulation in Peripheral Arterial Disease (Principle Investigator)Independent Order of Oddfellows - Sable Heart Fund2016–2017
Identification of Novel Platelet Inhibitors Principle InvestigatorIndependent Order of Oddfellows - Sable Heart Fund2013–2014
Platelets as biosensors and mediators of aortic aneurysm growthNational Institute of HealthPresent

Professional Biohttps://my.clevelandclinic.org/staff/25137-scott-cameron
Press Mentionhttp://www.scotsman.com/lifestyle/will-we-see-his-like-again-1-740088
Press Mentionhttps://consultqd.clevelandclinic.org/new-head-of-vascular-medicine-looks-to-enhance-collaborative-caregiving/